Fungal infections in cancer patients: An international autopsy survey |
| |
| Authors: | G. Bodey B. Bueltmann W. Duguid D. Gibbs H. Hanak M. Hotchi G. Mall P. Martino F. Meunier S. Milliken S. Naoe M. Okudaira D. Scevola J. van't Wout |
| |
| Affiliation: | (1) M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 47, 77030 Houston, Texas, USA;(2) University of Ulm, Ulm, Germany;(3) Montreal General Hospital, Montreal, Canada;(4) Pfizer International, Inc., New York, New York, USA;(5) Hanusch Hospital, Vienna, Austria;(6) Shinshu University Hospital, Matsumoto, Japan;(7) University of Heidelberg, Heidelberg, Germany;(8) University La Sapienza, Rome, Italy;(9) EORTC, Brussels, Belgium;(10) Royal Marsden Hospital, London, UK;(11) Toho University, Tokyo, Japan;(12) Kitazato University, Sagamihara, Japan;(13) University of Pavia, Pavia, Italy;(14) Leiden University, Leiden, The Netherlands |
| |
| Abstract: | ![]()
In an attempt to estimate the frequency of fungal infections among cancer patients, a survey of autopsy examinations was conducted in multiple institutions in Europe, Japan and Canada. Fungal infections were identified most often in leukemic patients and transplant recipients (25 % each). Fifty-eight percent of fungal infections were caused byCandida spp. and 30 % byAspergillus spp. There was considerable variability in the frequency of fungal infections in different countries. Nevertheless, this study clearly demonstrates that fungal infections represent a common complication in cancer patients, especially in patients with leukemia. |
| |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ |
|
